Beta Bloker Zehirlenmeleri

Walls RM, Hockberger RS, Gausche-Hill M. Rosen’s Emergency Medicine: Concepts and Clinical Practice, (Ninth edition). (2018) Philadelphia: Elsevier

Cruickshank JM. Are we misunderstanding beta-blockers. Int J Cardiol. 2007;120(1):10-27. doi:10.1016/j.ijcard.2007.01.069

Wax PM, Erdman AR, Chyka PA, et al. Beta-blocker ingestion: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2005;43(3):131-146.

Gummin DD, Mowry JB, Beuhler MC, et al. 2019 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 37th Annual Report. Clin Toxicol (Phila). 2020;58(12):1360-1541. doi:10.1080/15563650.2020.1834219

Menke NB, Walsh SJ, King AM. Cardiotoxicodynamics: Toxicity of Cardiovascular Xenobiotics. Emerg Med Clin North Am. 2015;33(3):563-595. doi:10.1016/j.emc.2015.04.007

Rotella JA, Greene SL, Koutsogiannis Z, et al. Treatment for beta-blocker poisoning: a systematic review. Clin Toxicol (Phila). 2020;58(10):943-983. doi:10.1080/15563650.2020.1752918

Tintinalli JE. (2020). Tintinalli's Emergency Medicine A Comprehensive Study Guide (Ninth edition) New York: McGraw Hill Medical Books

DeWitt CR, Waksman JC. Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity. Toxicol Rev. 2004;23(4):223-238. doi:10.2165/00139709-200423040-00003

Kline JA, Leonova E, Raymond RM. Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine. Crit Care Med. 1995;23(7):1251-1263. doi:10.1097/00003246-199507000-00016

Khalid MM, Galuska MA, Hamilton RJ. Beta-Blocker Toxicity. In: StatPearls. Treasure Island (FL): StatPearls Publishing; November 21, 2020.

Kerns W 2nd. Management of beta-adrenergic blocker and calcium channel antagonist toxicity. Emerg Med Clin North Am. 2007;25(2):309-viii. doi:10.1016/j.emc.2007.02.001

Love JN, Enlow B, Howell JM, et al. Electrocardiographic changes associated with beta-blocker toxicity. Ann Emerg Med. 2002;40(6):603-610. doi:10.1067/mem.2002.129829

Mladěnka P, Applová L, Patočka J, et al. Comprehensive review of cardiovascular toxicity of drugs and related agents. Med Res Rev. 2018;38(4):1332-1403. doi:10.1002/med.21476 Fung HT, Lai CH, Wong OF, et al. The use of glucagon and other antidotes in a case of beta-blocker and calcium channel blocker overdose. Hong Kong J Emerg Med. 2007;14(2):113–118.

Cole JB, Stellpflug SJ, Ellsworth H, et al. A blinded, randomized, controlled trial of three doses of high-dose insulin in poison-induced cardiogenic shock [published correction appears in Clin Toxicol (Phila). 2013 Dec;51(10):1246]. Clin Toxicol (Phila). 2013;51(4):201-207. doi:10.3109/15563650.2013.770152

Mégarbane B, Karyo S, Baud FJ. The role of insulin and glucose (hyperinsulinaemia/euglycaemia) therapy in acute calcium channel antagonist and beta-blocker poisoning. Toxicol Rev. 2004;23(4):215-222. doi:10.2165/00139709-200423040-00002

Palatnick W, Jelic T. Emergency department management of calcium-channel blocker, beta blocker, and digoxin toxicity. Emerg Med Pract. 2014;16(2):1-20.

Gunja N, Graudins A. Management of cardiac arrest following poisoning. Emerg Med Australas. 2011;23(1):16-22. doi:10.1111/j.1742-6723.2010.01369.x

Levine M, Skolnik AB, Ruha AM, et al. Complications following antidotal use of intravenous lipid emulsion therapy. J Med Toxicol. 2014;10(1):10-14. doi:10.1007/s13181-013-0356-1

Kerns W 2nd, Kline J, Ford MD. Beta-blocker and calcium channel blocker toxicity. Emerg Med Clin North Am. 1994;12(2):365-390.

Hayes BD, Gosselin S, Calello DP, et al. Systematic review of clinical adverse events reported after acute intravenous lipid emulsion administration. Clin Toxicol (Phila). 2016;54(5):365-404. doi:10.3109/15563650.2016.1151528

Vignesh C, Kumar M, Venkataraman R, et al. Extracorporeal Membrane Oxygenation in Drug Overdose: A Clinical Case Series. Indian J Crit Care Med. 2018;22(2):111-115. doi:10.4103/ijccm.IJCCM_417_17